Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

doi:10.1001/jama.2016.10542

. 2016 Sep 20;316(11):1211-1212.

doi: 10.1001/jama.2016.10542.

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Bradley D Stein¹, Mark Sorbero², Andrew W Dick³, Rosalie Liccardo Pacula⁴, Rachel M Burns², Adam J Gordon⁵

Affiliations

¹ RAND Corporation, Pittsburgh, Pennsylvania2University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² RAND Corporation, Pittsburgh, Pennsylvania.
³ RAND Corporation, Boston, Massachusetts.
⁴ RAND Corporation, Santa Monica, California.
⁵ University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

PMID: 27654608
PMCID: PMC5257276
DOI: 10.1001/jama.2016.10542

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Bradley D Stein et al. JAMA. 2016.

. 2016 Sep 20;316(11):1211-1212.

doi: 10.1001/jama.2016.10542.

Authors

Bradley D Stein¹, Mark Sorbero², Andrew W Dick³, Rosalie Liccardo Pacula⁴, Rachel M Burns², Adam J Gordon⁵

Affiliations

¹ RAND Corporation, Pittsburgh, Pennsylvania2University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² RAND Corporation, Pittsburgh, Pennsylvania.
³ RAND Corporation, Boston, Massachusetts.
⁴ RAND Corporation, Santa Monica, California.
⁵ University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

PMID: 27654608
PMCID: PMC5257276
DOI: 10.1001/jama.2016.10542

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. No other disclosures were reported.

Cited by

Increasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.
Holtrop JS, Mullen R, Curcija K, Rubinson C, Westfall JM, Nease DE Jr, Zittleman L. Holtrop JS, et al. Front Med (Lausanne). 2024 Oct 2;11:1450672. doi: 10.3389/fmed.2024.1450672. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39416870 Free PMC article.
Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.
Schuler MS, Dick AW, Gordon AJ, Saloner B, Kerber R, Stein BD. Schuler MS, et al. Drug Alcohol Depend. 2024 Jun 1;259:111290. doi: 10.1016/j.drugalcdep.2024.111290. Epub 2024 Apr 16. Drug Alcohol Depend. 2024. PMID: 38678682 Free PMC article.
Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
Wu LT, John WS, Mannelli P, Morse ED, Anderson A, Schwartz RP. Wu LT, et al. Addict Sci Clin Pract. 2023 Aug 2;18(1):45. doi: 10.1186/s13722-023-00399-6. Addict Sci Clin Pract. 2023. PMID: 37533071 Free PMC article.
Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads.
Griffin BA, Cabreros I, Saloner B, Gordon AJ, Kerber R, Stein BD. Griffin BA, et al. Subst Abus. 2023 Jul;44(3):136-145. doi: 10.1177/08897077231179824. Epub 2023 Jul 4. Subst Abus. 2023. PMID: 37401501 Free PMC article.
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.
Murray JP, Pucci G, Weyer G, Ari M, Dickson S, Kerins A. Murray JP, et al. Addict Sci Clin Pract. 2023 Jun 1;18(1):38. doi: 10.1186/s13722-023-00392-z. Addict Sci Clin Pract. 2023. PMID: 37264449 Free PMC article.

See all "Cited by" articles

References

1. Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947–1954. - PMC - PubMed
1. Symphony Health Solutions. IDV Integrated Dataverse. [Accessed July 1, 2016];2015 http://symphonyhealth.com/wp-content/uploads/2015/10/IDV-Product-Introdu....
1. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. - PubMed
1. Lo-Ciganic WH, Gellad WF, Gordon AJ, et al. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction. 2016;111(5):892–902. - PubMed
1. Netherland J, Botsko M, Egan JE, et al. BHIVES Collaborative. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244–251. - PMC - PubMed

Grants and funding

R01 DA032881/DA/NIDA NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947–1954. - PMC - PubMed

[2] Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947–1954. - PMC - PubMed

[3] Symphony Health Solutions. IDV Integrated Dataverse. [Accessed July 1, 2016];2015 http://symphonyhealth.com/wp-content/uploads/2015/10/IDV-Product-Introdu....

[4] Symphony Health Solutions. IDV Integrated Dataverse. [Accessed July 1, 2016];2015 http://symphonyhealth.com/wp-content/uploads/2015/10/IDV-Product-Introdu....

[5] Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. - PubMed

[6] Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. - PubMed

[7] Lo-Ciganic WH, Gellad WF, Gordon AJ, et al. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction. 2016;111(5):892–902. - PubMed

[8] Lo-Ciganic WH, Gellad WF, Gordon AJ, et al. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction. 2016;111(5):892–902. - PubMed

[9] Netherland J, Botsko M, Egan JE, et al. BHIVES Collaborative. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244–251. - PMC - PubMed

[10] Netherland J, Botsko M, Egan JE, et al. BHIVES Collaborative. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244–251. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Affiliations

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Conflict of interest statement

Similar articles

Cited by

References

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources